Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in ANAB — Anaptysbio, Inc

CIK 1596800 VANCOUVER, A1

Position in ANAB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,519,254
+$725,414 QoQ
Shares Held
141,026
-40.7% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#41
of 211 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. ANAB ranks #20 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANAB

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,519,254 141,026
2026-03-31 $8,793,840 158,562
2025-12-31 $5,937,636 122,476
2022-12-31 $882,130 28,465
2022-09-30 $1,679,428 65,834
2022-06-30 $1,487,539 73,278
2022-03-31 $1,940,280 78,427
2021-12-31 $3,060,402 88,069
2021-09-30 $2,383,359 87,882
2021-06-30 $2,078,267 80,149
2021-03-31 $1,694,200 78,617
2020-12-31 $1,625,761 75,617
2020-09-30 $1,289,897 87,451
2020-06-30 $2,385,705 106,791
2020-03-31 $1,538,757 108,900